Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Halting the progression of chronic nephropathy.

Ruth C Campbell1, Piero Ruggenenti, Giuseppe Remuzzi

  • 1Mario Negri Institute for Pharmacological Research, Bergamo, Italy.

Journal of the American Society of Nephrology : JASN
|December 6, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy.

Journal of the American Society of Nephrology : JASN·2015
Same author

International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology.

Lancet (London, England)·2015
Same author

Rare diseases and effective treatments: are we delivering?

Lancet (London, England)·2015
Same author

Direct reprogramming of human bone marrow stromal cells into functional renal cells using cell-free extracts.

Stem cell reports·2015
Same author

Renal progenitors derived from human iPSCs engraft and restore function in a mouse model of acute kidney injury.

Scientific reports·2015
Same author

Need for chronic kidney disease prevention programs in disadvantaged populations.

Clinical nephrology·2015
Same journal

Autosomal Dominant Tubulointerstitial Kidney Disease: My Kingdom for a Biomarker.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Beyond the Margin: Improving Noninferiority Trials of Kidney Transplant Immunosuppression.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Parathyroid Hormone Receptor 1 Facilitates Cyst Growth in Genetic Models of Autosomal Dominant Polycystic Kidney Disease.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Alanyl-tRNA Synthetase 1 and Cyst Growth in Autosomal Dominant Polycystic Kidney Disease.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Evaluating Barriers to Kidney Transplantation in the United States.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Comparing Catheters to Fistulas in Older Patients Starting Hemodialysis (ACCESS HD).

Journal of the American Society of Nephrology : JASN·2026
See all related articles

The global incidence of end-stage renal disease (ESRD) is rising, necessitating early nephropathy identification and treatment. Advances in understanding and treating chronic kidney disease offer hope for slowing, and potentially reversing, its progression.

Area of Science:

  • Nephrology
  • Public Health

Background:

  • Global incidence of end-stage renal disease (ESRD) is increasing.
  • ESRD presents a significant financial and societal burden due to rising patient numbers requiring renal replacement therapy.
  • There is a critical need for early detection and intervention in nephropathy to prevent progression to ESRD.

Purpose of the Study:

  • To highlight the growing global burden of end-stage renal disease (ESRD).
  • To emphasize the importance of early identification and treatment of nephropathy.
  • To review advances in understanding and treating chronic kidney disease.

Main Methods:

  • Review of global trends in end-stage renal disease (ESRD) incidence.
  • Analysis of the impact of ESRD on healthcare systems and productivity.

Related Experiment Videos

  • Synthesis of recent research on the progression of diabetic and nondiabetic proteinuric nephropathy.

    • Main Results:

    • End-stage renal disease (ESRD) incidence is increasing worldwide, with significant projected rises in patient numbers.
    • Effective treatments are available to slow the progression of chronic kidney disease.
    • Research has advanced the understanding of nephropathy progression.

    Conclusions:

    • Early identification and treatment of nephropathy are crucial to combat the rising tide of end-stage renal disease (ESRD).
    • Current research offers promising therapeutic strategies to slow or potentially reverse chronic kidney disease progression.
    • Continued research is vital for managing and mitigating the impact of ESRD globally.